Microbiological Advances and Strategies Toward Zero Rabies Deaths by 2030

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".

Deadline for manuscript submissions: 31 August 2025 | Viewed by 47

Special Issue Editor


E-Mail Website
Guest Editor
Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Dirección General de Epidemiología, Secretaría de Salud, Mexico City, Mexico
Interests: zoonoses; rabies virus; one health; bats
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Every nine minutes, a person dies from rabies, with 40% of victims being children in Asia and Africa. As dog bites cause almost all human rabies cases, increasing awareness, vaccinating dogs, and administering life-saving treatment after bites can prevent deaths. We have the vaccines, medicines, tools, and technologies needed to prevent dog-mediated rabies.

In recent years, many countries have strengthened rabies control efforts by scaling up dog vaccination programs, making human biologicals for post-exposure and pre-exposure prophylaxis more accessible, and engaging communities on rabies prevention. Dog-mediated rabies has been eliminated in Western Europe, Canada, the USA, and Japan. Additionally, the majority of the Latin American countries are free of human deaths from dog-transmitted rabies. Significant progress has been made in reducing rabies deaths in countries such as Bangladesh, the Philippines, Sri Lanka, Tanzania, Vietnam, and South Africa.

For a relatively low cost, it is possible to break the disease cycle and save lives. Investing in rabies elimination strengthens both human and veterinary health systems. A collaborative response through rabies programs contributes to disease prevention and societal preparedness. Integrated rabies elimination serves as a model for One Health collaboration.

In 2015, the world set a goal of zero human dog-mediated rabies deaths by 2030. Now, for the first time, four organizations, namely the World Health Organization (WHO), the World Organization for Animal Health (WOAH), the Food and Agriculture Organization of the United Nations (FAO), and the Global Alliance for Rabies Control (GARC), have joined forces as the United Against Rabies collaboration, aiming to reach this goal.

The implementation of recent WHO guidance on accelerated human vaccination schedules (including dose- and cost-saving options for pre-exposure and post-exposure) and the WOAH's international standards for rabies diagnosis, vaccination, and control in animals will increase feasibility and simplify programmatic delivery, allowing countries to move forward with the Global Strategic Plan.

In this Special Issue, titled "Microbiological Advances and Strategies Toward Zero Rabies Deaths by 2030", we invite all colleagues working on developing, improving, or strengthening the WHO's three objectives in The Global Strategic Plan for affected countries to share their advances and results on this topic.

Dr. Nidia Aréchiga Ceballos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rabies
  • zero by 30
  • rabies deaths

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop